* Aravive Inc ARAV.OQ ARAV.O is expected to show a fall
in
quarterly revenue when it reports results on May 10
(estimated).
* The Houston Texas-based company is expected to report a
61.1% decrease in revenue to $425 thousand from $1.09 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Aravive Inc is for
a loss
of 32 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 8.6%
in the last three months.
* Wall Street's median 12-month price target for Aravive Inc
is
$12, above its last closing price of $1.60.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 -0.17 -0.30 -0.46 Missed -53.3
Sep. 30 2022 -0.64 -0.64 -0.51 Beat 20.1
Jun. 30 2022 -0.68 -0.59 -0.61 Missed -3
Mar. 31 2022 -0.54 -0.53 -0.62 Missed -15.9
Dec. -0.60 -0.62 Missed -3
31 2021
Sep. 30 2021 -0.47 -0.46 -0.53 Missed -14.6
Jun. 30 2021 -0.38 -0.38 -0.35 Beat 8.9
Mar. 31 2021 -0.45 -0.45 -0.44 Beat 2.7
This summary was machine generated May 8 at 17:59 GMT. All
figures in US dollars unless otherwise stated